help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, Y. M.
Right arrow Articles by Repine, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, Y. M.
Right arrow Articles by Repine, J. E.

Am. J. Respir. Crit. Care Med., Vol 155, No. 5, May 1997, 1624-1628.

Mepacrine decreases lung leak in rats given interleukin-1 intratracheally

YM Lee, BM Hybertson, LS Terada, AJ Repine, HG Cho and JE Repine
Webb-Waring Institute for Biomedical Research and the Department of Medicine at the University of Colorado Health Sciences Center, Denver, USA.

We hypothesized that phospholipase A2 (PLA2) metabolites contribute to the acute, neutrophil-dependent, edematous lung leak that develops after administration of interleukin-1 (IL-1) intratracheally to rats and tested this premise by using mepacrine to inhibit PLA2 activity in vivo. We found that lung PLA2 activity, lung lavage phospholipid content, lung leak index, lung weight gain, and lung lavage protein concentrations were increased in rats given IL-1 intratracheally compared with sham-treated control rats. By comparison, lungs of mecaprine and IL-1-treated rats had decreased PLA2 activity, lavage phospholipid content, leak, weight gain, and lavage protein increases compared with rats given IL-1 intratracheally. Mepacrine treatment also decreased lung neutrophil accumulation, but not lung lavage cytokine- induced neutrophil chemoattractant (CINC) levels, in rats given IL-1 intratracheally. In parallel experiments, mepacrine treatment reduced the adhesion of human neutrophils to IL-1-treated human umbilical vein endothelial cells in vitro. Our results indicate that PLA2 activity participates in the lung neutrophil retention and pulmonary vascular leak that develops in rats given IL-1 intratracheally.


This article has been cited by other articles:


Home page
 PediatricsHome page
J. T. Naprawa, B. K. Bonsu, D. G. Goodman, and M. A. Ranalli
Serum Biomarkers for Identifying Acute Chest Syndrome Among Patients Who Have Sickle Cell Disease and Present to the Emergency Department
Pediatrics, September 1, 2005; 116(3): e420 - e425.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
J. G. Wagner and R. A. Roth
Neutrophil Migration Mechanisms, with an Emphasis on the Pulmonary Vasculature
Pharmacol. Rev., September 1, 2000; 52(3): 349 - 374.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. M. Lee, B. M. Hybertson, H. G. Cho, L. S. Terada, O. Cho, A. J. Repine, and J. E. Repine
Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally
Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L75 - L80.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society